ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 378 filers reported holding ENCOMPASS HEALTH CORP in Q3 2020. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $216,000 | -27.0% | 3,956 | -5.1% | 0.00% | 0.0% |
Q1 2022 | $296,000 | +10.4% | 4,169 | +16.6% | 0.00% | 0.0% |
Q3 2021 | $268,000 | -3.9% | 3,575 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $279,000 | -38.1% | 3,575 | -35.3% | 0.00% | -50.0% |
Q1 2021 | $451,000 | -19.3% | 5,524 | -18.3% | 0.00% | 0.0% |
Q4 2020 | $559,000 | -9.0% | 6,764 | -28.5% | 0.00% | -33.3% |
Q3 2020 | $614,000 | -4.8% | 9,454 | -9.2% | 0.00% | 0.0% |
Q2 2020 | $645,000 | -6.2% | 10,416 | -2.9% | 0.00% | -25.0% |
Q1 2020 | $688,000 | -1.4% | 10,731 | +6.5% | 0.00% | +33.3% |
Q4 2019 | $698,000 | +35.5% | 10,080 | +24.0% | 0.00% | 0.0% |
Q3 2019 | $515,000 | +9.6% | 8,132 | +10.0% | 0.00% | +50.0% |
Q2 2019 | $470,000 | +42.4% | 7,392 | +30.9% | 0.00% | 0.0% |
Q1 2019 | $330,000 | +10.0% | 5,647 | +15.9% | 0.00% | 0.0% |
Q4 2018 | $300,000 | -9.4% | 4,871 | +14.7% | 0.00% | 0.0% |
Q3 2018 | $331,000 | +56.1% | 4,246 | +35.0% | 0.00% | +100.0% |
Q2 2018 | $212,000 | -32.3% | 3,145 | -42.6% | 0.00% | -50.0% |
Q1 2018 | $313,000 | – | 5,481 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
RK Capital | 179,800 | $13,492,000 | 2.55% |
Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |